NEW YORK (Reuters Health) – Thiazolidinediones (TZDs) are linked to an increased risk for extremity fractures in women over age 65, findings from a large retrospective cohort study…
NEW YORK (Reuters Health) – Daily treatment with diazoxide prompts a decrease in HbA1c in patients with newly diagnosed type 1 diabetes, Norwegian researchers report in the December…
NEW YORK (Reuters Health) – Women with gestational diabetes are more likely to maintain target glucose levels with glyburide than with metformin, a randomized trial has shown. The…
NEW YORK (Reuters Health) – Only about half of small abdominal aortic aneurysms (AAA) will increase in size, and those that grow less than 1.5 mm per year…
NEW YORK (Reuters Health) – As a mass screening tool for diabetes and pre-diabetes in China, the fasting capillary blood glucose (FCG) test performs better than the hemoglobin…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, a body mass index (BMI) of 27.0 kg/meters-squared or higher increases the risk for left atrial/left atrial appendage…
NEW YORK (Reuters Health) – Pregnant women with type 1 diabetes had fewer severe hypoglycemic episodes when they started a preprandial insulin analog regimen before conception rather than…
NEW YORK (Reuters Health) – For diagnosing pulmonary embolism, single-photon emission CT (SPECT) lung scintigraphy is a viable alternative to CT pulmonary angiography (CTPA), and it offers advantages…